These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 18463201

  • 1. Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells.
    Riganti C, Doublier S, Costamagna C, Aldieri E, Pescarmona G, Ghigo D, Bosia A.
    Mol Pharmacol; 2008 Aug; 74(2):476-84. PubMed ID: 18463201
    [Abstract] [Full Text] [Related]

  • 2. RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells.
    Doublier S, Riganti C, Voena C, Costamagna C, Aldieri E, Pescarmona G, Ghigo D, Bosia A.
    Mol Cancer Res; 2008 Oct; 6(10):1607-20. PubMed ID: 18922976
    [Abstract] [Full Text] [Related]

  • 3. RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin.
    Xu H, Liu P, Liang L, Danesh FR, Yang X, Ye Y, Zhan Z, Yu X, Peng H, Sun L.
    Arthritis Rheum; 2006 Nov; 54(11):3441-51. PubMed ID: 17075836
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y, Kimoto K, Imaizumi M, Nakatsuka K.
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [Abstract] [Full Text] [Related]

  • 5. Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma.
    Riganti C, Orecchia S, Pescarmona G, Betta PG, Ghigo D, Bosia A.
    Int J Cancer; 2006 Jul 01; 119(1):17-27. PubMed ID: 16450390
    [Abstract] [Full Text] [Related]

  • 6. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells.
    Nakakuki T, Ito M, Iwasaki H, Kureishi Y, Okamoto R, Moriki N, Kongo M, Kato S, Yamada N, Isaka N, Nakano T.
    Arterioscler Thromb Vasc Biol; 2005 Oct 01; 25(10):2088-93. PubMed ID: 16123329
    [Abstract] [Full Text] [Related]

  • 7. Sabarubicin- (MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF-kB) activation: effect of parthenolide on their cytotoxicity.
    Bellarosa D, Binaschi M, Maggi CA, Goso C.
    Anticancer Res; 2005 Oct 01; 25(3B):2119-28. PubMed ID: 16158953
    [Abstract] [Full Text] [Related]

  • 8. Requirement of RhoA activity for increased nuclear factor kappaB activity and PC-3 human prostate cancer cell invasion.
    Hodge JC, Bub J, Kaul S, Kajdacsy-Balla A, Lindholm PF.
    Cancer Res; 2003 Mar 15; 63(6):1359-64. PubMed ID: 12649199
    [Abstract] [Full Text] [Related]

  • 9. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
    Penna G, Fibbi B, Amuchastegui S, Corsiero E, Laverny G, Silvestrini E, Chavalmane A, Morelli A, Sarchielli E, Vannelli GB, Gacci M, Colli E, Maggi M, Adorini L.
    Prostate; 2009 Apr 01; 69(5):480-93. PubMed ID: 19107880
    [Abstract] [Full Text] [Related]

  • 10. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q, Zhang X, Cardinal J, Cao Z, Guo Z, Shao L, Geller DA.
    Cancer Res; 2009 May 01; 69(9):3764-71. PubMed ID: 19383900
    [Abstract] [Full Text] [Related]

  • 11. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells.
    Ho WC, Dickson KM, Barker PA.
    Cancer Res; 2005 May 15; 65(10):4273-81. PubMed ID: 15899819
    [Abstract] [Full Text] [Related]

  • 12. RhoA and Rac1 signals in fMLP-induced NF-kappaB activation in human blood monocytes.
    Chen LY, Ptasznik A, Pan ZK.
    Biochem Biophys Res Commun; 2004 Jun 25; 319(2):629-35. PubMed ID: 15178452
    [Abstract] [Full Text] [Related]

  • 13. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
    Li M, Li Z, Sun X.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):219-23. PubMed ID: 18619957
    [Abstract] [Full Text] [Related]

  • 14. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
    Liang YJ, Shyu KG, Wang BW, Lai LP.
    Cardiology; 2008 Sep 04; 110(3):182-90. PubMed ID: 18057884
    [Abstract] [Full Text] [Related]

  • 15. Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB/iNOS.
    Mikael LG, Rozen R.
    Cardiovasc Res; 2008 Oct 01; 80(1):151-8. PubMed ID: 18540024
    [Abstract] [Full Text] [Related]

  • 16. RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility.
    Chang YW, Marlin JW, Chance TW, Jakobi R.
    Cancer Res; 2006 Dec 15; 66(24):11700-8. PubMed ID: 17178865
    [Abstract] [Full Text] [Related]

  • 17. Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways.
    Jung WK, Choi I, Lee DY, Yea SS, Choi YH, Kim MM, Park SG, Seo SK, Lee SW, Lee CM, Park YM, Choi IW.
    Int J Biochem Cell Biol; 2008 Dec 15; 40(11):2572-82. PubMed ID: 18571461
    [Abstract] [Full Text] [Related]

  • 18. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
    Tang D, Park HJ, Georgescu SP, Sebti SM, Hamilton AD, Galper JB.
    Life Sci; 2006 Sep 05; 79(15):1484-92. PubMed ID: 16740276
    [Abstract] [Full Text] [Related]

  • 19. NF-κB is not directly responsible for photoresistance induced by fractionated light delivery in HT-29 colon adenocarcinoma cells.
    Kuliková L, Mikeš J, Hýžďalová M, Palumbo G, Fedoročko P.
    Photochem Photobiol; 2010 Sep 05; 86(6):1285-93. PubMed ID: 20718930
    [Abstract] [Full Text] [Related]

  • 20. Signaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: involvement of ERK1/2, NF-kappaB and JAK/STAT pathways.
    Kar S, Ukil A, Das PK.
    Eur J Immunol; 2009 Mar 05; 39(3):741-51. PubMed ID: 19197936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.